By Jean McCoy Reverba EVP, Partnerships Perception is reality, as the saying goes. But sometimes,… Read More »Survey: 3 Surprising Things BioPharma Can Learn about Patients’ Perceptions
Published in Forbes By: Cheryl Lubbert, Forbes Councils Member When faced with online customer service… Read More »Authenticity In An Automated World: Surprising Guidance From Healthcare
By: Jean McCoy Diversity in clinical trials is a hot-button topic, with attention and programs… Read More »Embrace the Rainbow: Three Tips to Make DEI Foundational In Your Clinical Program
SOC 2 certification aligns Reverba with world-class organizations achieving the highest level of security and… Read More »Our Commitment to Patient Data Security and Privacy: Ongoing SOC 2®, Type II Certification
By: Jean McCoy A generation ago, HIV/AIDS patients had to “Act Up” to be heard.… Read More »The Patient Voice: Industry and Advocates Speak in Harmony
By: Reverba Clinical Partnerships Team More than 300 million people around the world live with… Read More »How Can We Have More Successful Rare Disease Trials?
By: Reverba Clinical Partnerships Team We have all made New Year’s resolutions – some we… Read More »Patient insights on trials: improving trust, the experience, and diversity.
By: Cheryl Lubbert Think about 2022 – what stands out to you the most? For… Read More »Patient Engagement: What Matters Most in 2023. A retrospective by Cheryl Lubbert
– 20th Anniversary demonstrates Reverba has the staying power and adaptability to continue leading the… Read More »Reverba Celebrates 20 Years of Amplifying Patient Voices
By: Cheryl Lubbert Today, we turn 20. Sixteen may be sweet, but twenty means so… Read More »It’s Our Anniversary: 20 Years, 20 Reasons to Believe
By: Cheryl Lubbert As a pioneer in patient engagement, Reverba wouldn’t be where it is… Read More »HBA Rising Star: Stephanie Hayes